Clifford Swan Investment Counsel Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Clifford Swan Investment Counsel reduced its stake in Monsanto Company by 4.16% during the most recent quarter end. The investment management company now holds a total of 158,074 shares of Monsanto Company which is valued at $16,637,289 after selling 6,859 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Monsanto Company makes up approximately 1.12% of Clifford Swan Investment Counsel’s portfolio.

Other Hedge Funds, Including , Marco Investment Management reduced its stake in MON by selling 1,855 shares or 5.41% in the most recent quarter. The Hedge Fund company now holds 32,411 shares of MON which is valued at $3,411,258. Monsanto Company makes up approx 0.50% of Marco Investment Management’s portfolio. First Personal Financial Services added MON to its portfolio by purchasing 634 company shares during the most recent quarter which is valued at $67,680. Monsanto Company makes up approx 0.02% of First Personal Financial Services’s portfolio.Blume Capital Management reduced its stake in MON by selling 396 shares or 46.05% in the most recent quarter. The Hedge Fund company now holds 464 shares of MON which is valued at $49,616. Monsanto Company makes up approx 0.05% of Blume Capital Management’s portfolio.Windsor Financial Group boosted its stake in MON in the latest quarter, The investment management firm added 525 additional shares and now holds a total of 42,848 shares of Monsanto Company which is valued at $4,560,741. Monsanto Company makes up approx 2.04% of Windsor Financial Group’s portfolio.

Monsanto Company opened for trading at $103.7 and hit $104.83 on the upside on Friday, eventually ending the session at $104.15, with a gain of 0.15% or 0.16 points. The heightened volatility saw the trading volume jump to 21,19,785 shares. Company has a market cap of $45,573 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.